Keyhani S, Cohen BE, Vali M, Hoggatt KJ, Bravata DM, Austin PC, Lum E, Hasin D, Grunfeld C, Shlipak MG. Association of smoking cannabis with cardiovascular events among veterans with coronary artery ...

Adeno-associated virus serotype 9 (AAV9) is currently considered the benchmark vector for clinical cardiac gene transfer applications but can entail severe hepatotoxicity because of its strong ...

Screen time in childhood and adolescence is positively associated with higher cardiometabolic risk, supported by consistent ...

BACKGROUND: Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease with no effective pharmacological treatments. The causal role of triglycerides (TGs) in AAA development remains ...

BACKGROUND: Whether cannabis is a risk factor for cardiovascular events is unknown. We examined the association between smoking cannabis and cardiovascular events in a cohort of older veterans (66 to ...

Public Access Policy Many research funding agencies require authors to publish their articles Open Access or deposit the Author Accepted Manuscript (the article after peer review and acceptance but ...

This real‐world evidence study of 6961 patients was conducted by applying pattern recognition methods to parse and extract CAC scores from CCTAs conducted as part of clinical screening for CVD risk.

BACKGROUND: The American Heart Association (AHA), in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and ...

In hyperaldosteronism-related hypertension, increased blood volume has been regarded as a primary contributor. However, increases in arterial contractility and total peripheral resistance are also ...

Poststroke anxiety (PSA) affects around 20% to 25% 1 of individuals and can negatively impact stroke rehabilitation 2 and quality of life. 3 Phobic disorders, generalized anxiety, panic disorder, and ...

Heart failure (HF) is an extreme high-risk condition with a prognosis similar to cancer. Yet, for patients with HF, stable or mild symptoms may be misperceived as low risk and justification to defer ...

Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m 2: SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy ...